MedDataX Logo

Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.

NCT ID: NCT00375141

Last Updated: 2007-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Completion Date

2007-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the trial is to compare clinical efficacy and occurrence of side effects in the treatment of photodamaged skin with Pulsed Dye Laser and Intense Pulsed Light.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Photodamaged Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulsed dye laser, Intense pulsed light

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mild to moderate bilateral facial photodamage
* Symmetry in the facial area of wrinkles, skin texture, pigmentary changes and telangiectasia
* Fitzpatrick's skin type of Type I, II, or III, without significant tan
* Age \> 40 years
* Able to read and comprehend Danish
* Informed consent agreement signed by the subject
* Willingness to follow the treatment schedule and posttreatment follow-up evaluations
* Willingness to allow photographs of the treated area to be taken for evaluation of efficacy.

Exclusion Criteria

* Scarring or infection of the area to be treated
* Known photosensitivity
* Presence of a suntan in the area to be treated
* Subjects taken medication known to induce photosensitivity in the previous three months
* Known anticoagulation or thromboembolic conditions
* Subjects taking anticoagulation medication
* Subjects taking Accutane within the past 6 months
* Subjects treated with aspirins or anti-inflammatory drugs
* Subjects who are immunocompromised or have a medical history that is inappropriate for the study per the investigator's clinical judgment.
* Dermabrasion, chemical peel, laser or IPL treatment, or collagen injection therapy in the facial area in the past 12 months.
* Previous formation of hypertrophic scars or keloids
* Subjects who are pregnant or lactating
* Asymmetry in the facial area of wrinkles, skin texture, pigmentary changes and telangiectasia
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bispebjerg Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Merete Hædersdal

Role: PRINCIPAL_INVESTIGATOR

Bispebjerg Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bispebjerg Hospital

Copenhagen, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KF-01-316279

Identifier Type: -

Identifier Source: org_study_id